Snowball logo
logo
AVTX

Avalo Therapeutics Inc

AVTX β€’ NASDAQ
$19.74+$0.47Β  (2.44%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
5.39818.051.9240.4410.0590.059
COGS
1.4913.4341.284(0.366)0.344-
Gross Profit
3.90714.620.640.8070.059-
Operating Expenses & Income
Operating Income
(82.13)(37.44)(27.35)(68.51)(72.92)(91.36)
Total Operating Expenses
86.0452.0627.9969.3272.9881.41
R&D Expenses
59.8431.3113.7852.0850.0864.35
Selling General & Admin Expenses
2320.6410.2716.4522.4326.66
Earnings from Continuing Operations
Interest Expense
(2.391)(4.17)(3.417)(3.317)--
Interest Income
-----4.681
Income Tax Expense
(0.196)0.0280.0140.1140.1650.171
Net Income
Net Income
(84.38)(41.66)(31.54)(35.13)(78.26)(100.3)
Supplemental
EBIT
(82.15)(37.46)(23.44)(35.02)(78.09)(100.2)
EBITDA
(80.5)(37.29)(23.29)(34.85)(77.75)(100)
In millions of USD, except % and values per 1 share